|
Resolution: standard / high Figure 1.
Examples of discrepancies of HER2 FISH status between primary breast cancers and matched distant metastases. HER2 (gene encoding human EGF-like receptor 2) fluorescence in situ hybridisation (FISH) status on histological specimens (a, c, e) and matched cytologies
of distant metastases (b, d, f). (a, b) Discrepancy due to interpretational difficulty. High-level amplification in primary
tumour (a), and rare amplified metastatic cells in pleura effusion that had been overlooked
(b). (c, d) Discrepancy due to heterogeneity. Rare tumour cells (arrow) with amplification in
the primary breast cancer (c), and metastatic cells in pleural effusion with amplification
(d). (e, f) True discrepancy. HER2-negative primary breast cancer (e), and amplification in metastatic cells (f). Original
magnifications ×630 to 1,000.
Tapia et al. Breast Cancer Research 2007 9:R31 doi:10.1186/bcr1676 |